TOWARDS STANDARDIZATION IN GAMMA-CAMERA RENOGRAPHY

[1] Cosgriff P.S., UK gamma camera renography survey, Nucl Med Commun, 214, (1989)

[2] Britton K.E., Busemann Sokole E., Quality assurance in nuclear medicine software and 'COST, Nucl Med Commun, 11, pp. 334-338, (1990)

[3] Bergmann H., Mostbeck A., Kletter K., Et al., Empfehlungen ziir durchfuhrung von nuklear-medizinischen nierenfunk- tionsuntersuchungen mit gammakamera und computer, Acta Medica Austriaca, 43, pp. 1-19, (1991)

[4] Cosgriff P.S., Renal Investigations Using Radionuclides

[5] Piepsz A., Hahn R.I., Et al., A radiopharmaceutical schedule for imaging in paediatrics, Eur J. Nucl Med, 17, pp. 127-129, (1990)

[6] Nimmon C.C., Britton K.E., Bomanji J., Et al., Quantitation of the frusemide response, with a comparison with parenchymal transit time analysis in the Tc-99m DTPA renal study, Nuklearmedizin, Proceedings of the European Nuclear Medicine Congress, pp. 472-476, (1988)

[7] Nimmon C.C., Britton K.E., Al-Nahhas A., Et al., ⁹⁹tc^m MAG3 (Mercapto acetyl triglycine): A renal pharmaceutical for routine use, Dynamic Functional Studies in Nuclear Medicine in Developing Countries, pp. 163-175, (1989)

[8] Britton K.E., Nimmon C.C., Whitfield H.N., Et al., The evaluation of obstructive nephropathy by means of parenchymal retention functions, Radionuclides in Nephrology, pp. 151-154, (1980)

[9] Britton K.E., Nawaz M.K., Whitfield H.N., Et al., Obstructive nephropathy: Comparison between parenchymal transit time index and frusemide diuresis, Br J. Urol, 59, pp. 127-132, (1987)

[1] Cosgriff P.S., UK gamma camera renography survey, Nucl Med Commun, 214, (1989)

[2] Britton K.E., Busemann Sokole E., Quality assurance in nuclear medicine software and 'COST, Nucl Med Commun, 11, pp. 334-338, (1990)

[3] Bergmann H., Mostbeck A., Kletter K., Et al., Empfehlungen ziir durchfuhrung von nuklear-medizinischen nierenfunk- tionsuntersuchungen mit gammakamera und computer, Acta Medica Austriaca, 43, pp. 1-19, (1991)

[4] Cosgriff P.S., Renal Investigations Using Radionuclides

[5] Piepsz A., Hahn R.I., Et al., A radiopharmaceutical schedule for imaging in paediatrics, Eur J. Nucl Med, 17, pp. 127-129, (1990)

[6] Nimmon C.C., Britton K.E., Bomanji J., Et al., Quantitation of the frusemide response, with a comparison with parenchymal transit time analysis in the Tc-99m DTPA renal study, Nuklearmedizin, Proceedings of the European Nuclear Medicine Congress, pp. 472-476, (1988)

[7] Nimmon C.C., Britton K.E., Al-Nahhas A., Et al., ⁹⁹tc^m MAG3 (Mercapto acetyl triglycine): A renal pharmaceutical for routine use, Dynamic Functional Studies in Nuclear Medicine in Developing Countries, pp. 163-175, (1989)

[8] Britton K.E., Nimmon C.C., Whitfield H.N., Et al., The evaluation of obstructive nephropathy by means of parenchymal retention functions, Radionuclides in Nephrology, pp. 151-154, (1980)

[9] Britton K.E., Nawaz M.K., Whitfield H.N., Et al., Obstructive nephropathy: Comparison between parenchymal transit time index and frusemide diuresis, Br J. Urol, 59, pp. 127-132, (1987)